MP tables questions on iSoft accounting

  • 26 July 2004


iSoft, a leading supplier of clinical software under the NHS’ National Programme for IT, has come under parliamentary scrutiny over its accounting and suspension of a director, who has just been re-elected to the board while suspended.


Paul Farrelly, Labour MP for Newcastle-under-Lyme has tabled questions to the Secretary of State for Health on whether the Department of Health has undertaken reviews “into the financial viability of (a) the contractors and (b) the sub-contractors working on the NHS National Programme for Information Technology."


In another question to the Secretary of State Farrelly asks: “if the Department will ask Accenture to report on the (a) financial standing and (b) accounting treatment of revenues and profits at iSoft."


Speaking to the Guardian Farelly, a former financial journalist, explained the reason for his questions. “I have asked a number of questions of the government regarding the processes it goes through to vet companies involved in crucial projects."


The 26 July Guardian article goes on to report that iSoft has stressed how open its relationship is with both Accenture, the prime local service provider for the North East and East of England, and NPfIT.  “The National Programme has been very thorough in scrutinizing the capability of all its providers."


“For the record, I can categorically confirm that there are no issues with iSoft’s accounting practices or financial viability," an iSoft spokesperson is quoted as saying.


The Guardian also reports that it is in dispute with iSoft over its alleged possession of confidential information and documents, particularly a report prepared by Deloitte as part of due diligence work for Torex during the course of its merger with iSoft. 


Farrelly has also asked the Secretary of State for Health whether the department has enquired as to why in March this year iSoft suspended one of its executive directors, Mark Woodbridge.


On 22 July, iSoft board directors and major shareholders voted to re-elect Woodridge as a director – despite the fact that he had been suspended four months earlier.  There is no suggestion that Woodbridge has done anything wrong, and Tim Whitson, iSoft’s chief executive, is on record as describing the matter as ‘confidential’.


Woodbridge, who joined iSoft as business development director from his position as finance director at Torex, following the £700m merger of iSoft and rival Torex in late 2003.  The only other one of his Torex colleagues to join the iSoft board was Chris Moore, who was appointed as chief executive, but resigned as a director in February.


With Parliament now in recess for the summer none of the Parliamentary questions tabled by Farrelly are due to be answered before 7 September.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

Wes Streeting: We can make Britain a powerhouse for MedTech

Wes Streeting: We can make Britain a powerhouse for MedTech

Health secretary Wes Streeting has pledged that the new government will “make Britain a powerhouse for life sciences and medical technology”.
What NHS tech and AI really need from the new government

What NHS tech and AI really need from the new government

The major parties see a big role for tech in easing pressure on the NHS and improving healthcare. What’s missing is a plan to make…
Atos denies that financial issues could have ‘severe’ effects on NHS

Atos denies that financial issues could have ‘severe’ effects on NHS

French IT giant Atos has denied reports that it is facing financial issues that could severely impact the NHS and other public services.